{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T23:37:31Z","timestamp":1776123451441,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":1926,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL081588"],"award-info":[{"award-number":["HL081588"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL102260"],"award-info":[{"award-number":["HL102260"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL126810"],"award-info":[{"award-number":["HL126810"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Midwest Athletes Against Childhood Cancer"},{"name":"Blood Center Research Fund"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/jth.13742","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T17:51:23Z","timestamp":1495561883000},"page":"1559-1566","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clinical and laboratory phenotype variability in type 2M von Willebrand disease"],"prefix":"10.1016","volume":"15","author":[{"given":"A.L.","family":"Doruelo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"Haberichter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"Christopherson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.N.","family":"Boggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.R.","family":"Lentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.D.","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.R.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.H.","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13742_bb0010","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0021-9258(17)42483-5","article-title":"von willebrand factor. A reduced and alkylated 52\/48\u2010kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib","volume":"261","author":"Fujimura","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13742_bb0015","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13742_bb0020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI115285","article-title":"150\u2010kD von willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen","volume":"88","author":"Rand","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13742_bb0025","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the subcommittee on von willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the national heart, lung, and blood institute (NHLBI) expert panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13742_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MBC.0b013e32834a7e01","article-title":"Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von willebrand factor assays","volume":"22","author":"Favaloro","year":"2011","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13742_bb0040","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS\u201013 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0045","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2012.04661.x","article-title":"Different bleeding risk in type 2 A and 2 M von Willebrand disease: a two\u2010year prospective study in 107 patients","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0050","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1111\/j.1538-7836.2010.03975.x","article-title":"ISTH\/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders","volume":"8","author":"Rodeghiero","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0055","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in african americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0060","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2011-10-384610","article-title":"VWF mutations and new sequence variations identified in healthy controls are more frequent in the african\u2010american population","volume":"119","author":"Bellissimo","year":"2012","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1538-7836.2009.03290.x","article-title":"Genetic alteration of the D2 domain abolishes von willebrand factor multimerization and trafficking into storage","volume":"7","author":"Haberichter","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0070","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0075","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF : CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0080","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain\u2010of\u2010function GPIb ELISA assay for VWF activity in the zimmerman program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0085","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1373\/clinchem.2012.199000","article-title":"Collagen binding provides a sensitive screen for variant von Willebrand disease","volume":"59","author":"Flood","year":"2013","journal-title":"Clin Chem"},{"key":"10.1111\/jth.13742_bb0090","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.V88.7.2559.bloodjournal8872559","article-title":"Type 2M:Milwaukee\u20101 von Willebrand\u00a0disease: an in\u2010frame deletion in the Cys509\u2010Cys695 loop of the von willebrand factor A1 domain causes deficient binding of von willebrand factor to platelets","volume":"88","author":"Mancuso","year":"1996","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0095","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/hae.12117","article-title":"Variability in platelet\u2010 and collagen\u2010binding defects in type 2M von Willebrand disease","volume":"19","author":"Larsen","year":"2013","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13742_bb0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2014-11-613935","article-title":"Variable content of von willebrand factor mutant monomer drives the phenotypic variability in a family with von Willebrand disease","volume":"126","author":"Chen","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0105","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.20470","article-title":"von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of spain (galicia)","volume":"80","author":"Penas","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13742_bb0110","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von willebrand disease in the european study, molecular and clinical markers for the diagnosis and management of type 1 von willebrand disease (MCMDM\u20101VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/jth.13742_bb0120","doi-asserted-by":"crossref","first-page":"E431","DOI":"10.1002\/ajh.24474","article-title":"Variable bleeding phenotype in an amish pedigree with von Willebrand disease","volume":"91","author":"Gupta","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1111\/jth.13742_bb0125","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1538-7836.2009.03594.x","article-title":"Limitations of the ristocetin cofactor assay in measurement of von willebrand factor function","volume":"7","author":"Flood","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0130","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-2006-947863","article-title":"Laboratory tests for measurement of von willebrand factor show poor agreement among different centers: results from the united kingdom national external quality assessment scheme for blood coagulation","volume":"32","author":"Kitchen","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13742_bb0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von willebrand factor laboratory analysis: an overview from the european concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/jth.13742_bb0140","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"10.1111\/jth.13742_bb0145","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1074\/jbc.M115.703850","article-title":"Mutational constraints on local unfolding inhibit the rheological adaptation of von willebrand factor","volume":"291","author":"Tischer","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13742_bb0150","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/jth.12457","article-title":"Microfluidic assay of hemophilic blood clotting: distinct deficits in platelet and fibrin deposition at low factor levels","volume":"12","author":"Colace","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13742_bb0155","doi-asserted-by":"crossref","first-page":"10396","DOI":"10.1074\/jbc.273.17.10396","article-title":"Crystal structure of the von willebrand factor A1 domain and implications for the binding of platelet glycoprotein ib","volume":"273","author":"Emsley","year":"1998","journal-title":"J Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13742","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622043318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13742\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:19:19Z","timestamp":1761535159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622043318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1538783622043318"],"URL":"https:\/\/doi.org\/10.1111\/jth.13742","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and laboratory phenotype variability in type 2M von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13742","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}